Michael Sarcone
Stock Analyst at Jefferies
(0.38)
# 3,980
Out of 4,711 analysts
5
Total ratings
33.33%
Success rate
-17.89%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $81.17 | +17.04% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $150.88 | -17.15% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $7.25 | +37.93% | 1 | Mar 21, 2023 | |
| AXGN Axogen | Assumes: Buy | $15 | $15.64 | -4.09% | 1 | Nov 11, 2022 | |
| EDAP EDAP TMS | Initiates: Buy | $11 | $2.19 | +402.28% | 1 | Nov 1, 2022 |
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $81.17
Upside: +17.04%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $150.88
Upside: -17.15%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $7.25
Upside: +37.93%
Axogen
Nov 11, 2022
Assumes: Buy
Price Target: $15
Current: $15.64
Upside: -4.09%
EDAP TMS
Nov 1, 2022
Initiates: Buy
Price Target: $11
Current: $2.19
Upside: +402.28%